Lonza is poised for growth amid margin recovery, onshoring opportunities, and strong profit projections. Read more on LZAGY ...

Mumbai: Piramal Pharma Limited has announced the commencement of commercial production of Sevoflurane at the Company’s facility located at Digwal, Telangana, India. "This was achieved by creating ...

CDMO, has appointed Dr James Miskin as Non-Executive Director. James brings extensive experience in the cell and gene therapy sector, following a 23-year tenure at Oxford Biomedica. He oversaw ...

Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice ... real-life risks in the manufacturing facility. If this level of technology ...

“This new facility, along with our existing cash, which was $257.4 million at [30th September] 2023, provides us with additional financial flexibility to support Verona Pharma’s continued ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,128.40 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

31 March 2025 US pharma major Eli Lilly has unveiled new Phase II data showing that its RNA-based therapy lepodisiran produced significant and lasting reductions in levels of lipoprotein(a), a known ...

This lease extension gives Northstar the option to retrofit the Empower Delta Facility, formerly home to its pilot facility, into a commercial-scale operation.

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

On Friday, the president said specific pharma tariffs were coming “soon.” He gave no details on what those tariffs would look like or exactly how existing blanket levies on goods from China, Canada ...

Nuveen Churchill Direct Lending posted solid 2024 results, growing net & total investment income YoY despite a slight ...